Algert Global LLC Vaxcyte, Inc. Transaction History

Algert Global LLC

$4.04 Billion
Q1 2025

A detailed history of Algert Global LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Algert Global LLC holds 56,179 shares of PCVX stock, worth $2.09 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

56,179

Previous 73,069 23.12%

Holding current value

$2.09 Million

Previous $5.98 Million 64.54%

% of portfolio

0.05%

Previous 0.14%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$37.76 - $92.13 $637,766 - $1.56 Million	-16,890 Reduced 23.12%	56,179 $2.12 Million
Q4 2024 Feb 14, 2025	BUY	$80.97 - $117.93 $2.73 Million - $3.98 Million	33,777 Added 85.96%	73,069 $5.98 Million
Q3 2024 Nov 12, 2024	BUY	$70.52 - $117.12 $320,160 - $531,724	4,540 Added 13.06%	39,292 $4.49 Million
Q2 2024 Aug 14, 2024	BUY	$60.06 - $78.77 $1.29 Million - $1.69 Million	21,442 Added 161.1%	34,752 $2.62 Million
Q1 2024 May 14, 2024	SELL	$59.79 - $81.05 $64,573 - $87,534	-1,080 Reduced 7.51%	13,310 $909,000
Q4 2023 Feb 14, 2024	SELL	$45.35 - $63.41 $471,640 - $659,464	-10,400 Reduced 41.95%	14,390 $904,000
Q3 2023 Nov 13, 2023	BUY	$46.0 - $53.1 $128,340 - $148,149	2,790 Added 12.68%	24,790 $1.26 Million
Q2 2023 Aug 14, 2023	BUY	$34.66 - $54.07 $5,649 - $8,813	163 Added 0.75%	22,000 $1.1 Million
Q1 2023 May 12, 2023	BUY	$36.27 - $47.2 $792,027 - $1.03 Million	21,837 New	21,837 $818,000
Q3 2022 Nov 15, 2022	BUY	$21.69 - $28.53 $350,965 - $461,643	16,181 Added 55.18%	45,505 $1.09 Million
Q2 2022 Aug 15, 2022	BUY	$17.68 - $26.58 $350,948 - $527,613	19,850 Added 209.52%	29,324 $638,000
Q1 2022 May 16, 2022	SELL	$17.46 - $26.36 $57,478 - $86,777	-3,292 Reduced 25.79%	9,474 $229,000
Q4 2021 Feb 14, 2022	BUY	$19.32 - $26.45 $28,593 - $39,146	1,480 Added 13.11%	12,766 $304,000
Q3 2021 Nov 15, 2021	BUY	$20.26 - $26.97 $228,654 - $304,383	11,286 New	11,286 $286,000

Others Institutions Holding PCVX

# of Institutions

345

Shares Held

136M

Call Options Held

348K

Put Options Held

250K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $2.21B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Vaxcyte, Inc. Transaction History